A Randomized Placebo Controlled Clinical Trial of a Metabolic Shifting Probiotic, Sugar Shift, for the Treatment of T2DM medrxiv.org/content/10.1101/20

Sign in to participate in the conversation
CleverLibre Social

CleverLibre Social is an inclusive social instance for open discussion, learning, and community.
All cultures welcome.
Hate speech and harassment strictly forbidden.